Validated using a knockout cell line
Recombinant
RabMAb

Anti-ERK2 antibody [E460] (ab32081)

Publishing research using ab32081? Please let us know so that we can cite the reference in this datasheet.

ab32081 has been referenced in 7 publications.

  • You W  et al. High-Throughput Screening Identifies miR-451 as a Pleiotropic Modulator That Suppresses Gastric Cancer Metastasis. SLAS Technol 22:136-143 (2017). PubMed: 27780852
  • Ho JY  et al. MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis. Oncotarget 8:22443-22459 (2017). WB ; Human . PubMed: 27705918
  • He L  et al. miR-9 functions as a tumor inhibitor of cell proliferation in epithelial ovarian cancer through targeting the SDF-1/CXCR4 pathway. Exp Ther Med 13:1203-1208 (2017). WB ; Human . PubMed: 28413458
  • Zhu Z  et al. Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 34:95 (2015). IHC-P ; Human . PubMed: 26338103
  • Chen M  et al. Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex. J Natl Cancer Inst 105:405-23 (2013). PubMed: 23446755
  • Emmanuel C  et al. Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis. PLoS One 6:e17617 (2011). IHC-P ; Human . PubMed: 21423607
  • Burkhard K & Shapiro P Use of inhibitors in the study of MAP kinases. Methods Mol Biol 661:107-22 (2010). PubMed: 20811979

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up